{"transactions":[{"id":1622076,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":93939,"kind":"person","name":"Gerber Brianna","position":1,"cik":"0001942395","reported_name":"Gerber Brianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Options (right to buy)","published_at":"2024-02-24T02:00:40.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":213886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the option shall vest on February 22, 2025 and the remaining shares subject to the option shall vest in a series of 24 equal monthly installments thereafter."}],"balance_after":213886,"derivative":{"exercise_price":1.52,"exercise_date":"2025-02-22","expiration_date":"2034-02-21","underlying":"Common Stock","underlying_shares":213886},"source":{"system":"sec-edgar","filing":"0001628280-24-006725","document":"wk-form4_1708740022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828024006725/wk-form4_1708740022.xml","form_type":"4"}},{"id":1723514,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":93939,"kind":"person","name":"Gerber Brianna","position":1,"cik":"0001942395","reported_name":"Gerber Brianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-04T21:12:33.000Z","date":"2023-12-01","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.41,"value":7050.0,"ownership":{"direct":true},"balance_after":27436,"source":{"system":"sec-edgar","filing":"0001628280-23-040625","document":"wk-form4_1701724341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828023040625/wk-form4_1701724341.xml","form_type":"4"}},{"id":1807062,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":93939,"kind":"person","name":"Gerber Brianna","position":1,"cik":"0001942395","reported_name":"Gerber Brianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-08-16T01:11:46.000Z","date":"2023-08-12","kind":"exercise","planned":false,"acquired":false,"shares":22436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On August 12, 2022, the Reporting Person was awarded RSUs which will be settled in shares of Common Stock when vested."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of restricted stock units (\"RSUs\") previously granted to the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs shall vest and be settled in shares of Common Stock in three substantially equal annual installments beginning on August 12, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSUs shall vest and be settled in shares of Common Stock in three substantially equal annual installments beginning on August 12, 2023."}],"balance_after":44872,"derivative":{"underlying":"Common Stock","underlying_shares":22436},"source":{"system":"sec-edgar","filing":"0001628280-23-029599","document":"wk-form4_1692148297.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828023029599/wk-form4_1692148297.xml","form_type":"4"}},{"id":1807061,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":93939,"kind":"person","name":"Gerber Brianna","position":1,"cik":"0001942395","reported_name":"Gerber Brianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-16T01:11:46.000Z","date":"2023-08-12","kind":"exercise","planned":false,"acquired":true,"shares":22436,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of restricted stock units (\"RSUs\") previously granted to the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 12, 2022, the Reporting Person was awarded RSUs which will be settled in shares of Common Stock when vested."}],"balance_after":22436,"source":{"system":"sec-edgar","filing":"0001628280-23-029599","document":"wk-form4_1692148297.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828023029599/wk-form4_1692148297.xml","form_type":"4"}},{"id":2006735,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":93939,"kind":"person","name":"Gerber Brianna","position":1,"cik":"0001942395","reported_name":"Gerber Brianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Options (right to buy)","published_at":"2023-02-17T22:09:27.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":163996,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the option shall vest on February 15, 2024 and the remaining shares subject to the option shall vest in a series of 24 equal monthly installments thereafter."}],"balance_after":163996,"derivative":{"exercise_price":1.82,"exercise_date":"2024-02-15","expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":163996},"source":{"system":"sec-edgar","filing":"0001628280-23-004092","document":"wf-form4_167667171935135.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828023004092/wf-form4_167667171935135.xml","form_type":"4"}},{"id":2186665,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":93939,"kind":"person","name":"Gerber Brianna","position":1,"cik":"0001942395","reported_name":"Gerber Brianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance / Interim CFO"}}],"security":"Restricted Stock Unit","published_at":"2022-08-13T01:06:34.000Z","date":"2022-08-12","kind":"grant","acquired":true,"shares":67308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On August 12, 2022, the reporting person was awarded Restricted Stock Units (\"RSUs\") which will be settled in shares of Common Stock when vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs shall vest and be settled in shares of Common Stock in three substantially equal annual installments beginning on August 12, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs shall vest and be settled in shares of Common Stock in three substantially equal annual installments beginning on August 12, 2023."}],"balance_after":67308,"derivative":{"underlying":"Common Stock","underlying_shares":67308},"source":{"system":"sec-edgar","filing":"0001628280-22-022756","document":"wf-form4_166035275685057.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828022022756/wf-form4_166035275685057.xml","form_type":"4"}},{"id":2186664,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":93939,"kind":"person","name":"Gerber Brianna","position":1,"cik":"0001942395","reported_name":"Gerber Brianna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Finance / Interim CFO"}}],"security":"Employee Stock Options (right to buy)","published_at":"2022-08-13T01:06:34.000Z","date":"2022-08-12","kind":"grant","acquired":true,"shares":100460,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the option shall vest on August 12, 2023 and the remaining shares subject to the option shall vest in a series of 24 equal monthly installments thereafter."}],"balance_after":100460,"derivative":{"exercise_price":1.69,"exercise_date":"2023-08-12","expiration_date":"2032-08-11","underlying":"Common Stock","underlying_shares":100460},"source":{"system":"sec-edgar","filing":"0001628280-22-022756","document":"wf-form4_166035275685057.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828022022756/wf-form4_166035275685057.xml","form_type":"4"}}]}